Hawe E, Baillie L, Praet C. The direct cost of atrial fibrillation to the NHS in the UK. November 2008. ed. London: United Kingdom. OHE consulting report; 2008.
Andrews EB, Irish WD, Gilsenan AW, Campbell WH. Evaluation of therapeutic risk management programs. In: Hartzema AG, Tilson HH, Arnold Chan K, editors. Pharmacoepidemiology and therapeutic risk management. 1st ed. Cincinnati: United States. Harvey Whitney Books; 2008. p.637-52.
Andrews EB, Gilsenan AW, Cook SF. Therapeutic risk management interventions: feasibility and effectiveness. In: Pharmacoepidemiology and therapeutic risk management. Cincinnati: United States. Harvey Whitney Books; 2008. p.613-33.
Rothman KJ, Greenland S, Lash TL. Case-control studies. In: Everitt B, Melnick E, editors. Encyclopedia of quantitative risk analysis and assessment. New York: United States. Wiley; 2008.
Ryan M, Gerard K, Watson V, Street DJ, Burgess L. Practical issues in conducting a discrete choice experiment. In: Ryan M, Gerard K, Amaya-Amaya M, editors. Using discrete choice experiments to value health and health care. 1st ed. Dordrecht: The Netherlands. Springer Dordrecht; 2008. p.73-97. doi: 10.1007/978-1-4020-5753-3
Hawe E. Compendium of health statistics 2008. 19th Edition ed. London: United Kingdom. Radcliffe publishing; 2008.
Rothman KJ, Boice, Jr JD. Epidemiologic analysis with a programmable calculator. With an Appendix for the HP-41CV by H. Austin ed. Boston: MA. Epidemiology Resources, Inc; 1982.